In summary, our study uncovered the existence of the miR-182-5p/CMTM7/CTNNA1/CTNNB1/TCF3 regulation loop in breast cancer, which may provide novel targets and promising strategies for breast cancer therapy. This evidence concerns the gene CTNNA1 and breast carcinoma.